查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1678795

全球造口护理设备市场 - 2025 年至 2033 年

Global Ostomy Care Devices Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024 年全球造口护理设备市场规模达到 35.4 亿美元，预计到 2033 年将达到 75.1 亿美元，在 2025-2033 年预测期内的复合年增长率为 7.8%。

造口护理设备是用于协助个人进行造口手术（例如结肠造口术、迴肠造口术或泌尿道造口术）的医疗产品，处理废物并确保患者舒适。技术、气味控制、防洩漏和亲肤材料的进步提高了患者的生活品质。造口护理设备市场涵盖为接受造口手术的个人提供支援的产品的生产、分销和销售。

造口术是透过手术将消化系统或泌尿系统的一部分转移到身体的外部开口，即所谓的造口。此手术通常用于治疗大肠直肠癌、发炎性肠道疾病（如克隆氏症和溃疡性结肠炎）、膀胱癌和某些先天性疾病等患者。

市场动态：

驱动因素与约束因素

发炎性肠道疾病率上升

由于克隆氏症和溃疡性结肠炎等发炎性肠道疾病 (IBD) 的增多，全球造口护理设备市场正在蓬勃发展。这些慢性病通常需要手术干预，从而导致对造口护理产品的需求增加。 IBD 发生率不断上升，尤其是在已开发国家，原因在于饮食习惯的改变、压力和遗传倾向。

例如，2024 年的一项研究估计，23.9 亿美国人患有 IBD，其中 125 万人患有溃疡性结肠炎，101 万人患有克隆氏症。北美是发炎性肠道疾病发生率最高的地区，美国每 10 万人每年有 721 例。溃疡性结肠炎的盛行率高于克隆氏症，但克隆氏症在10岁以下儿童中更为常见。

IBD 的发生率不断上升，影响了 239 万美国人，这推动了对造口护理设备的需求，特别是在发病率最高的北美地区，从而导致先进的造口产品和配件的市场显着增长。

高成本和有限的报销政策

造口护理设备的需求不断增加，但产品成本高和报销政策不充分阻碍了市场成长。患者，特别是中低收入国家的患者，在取得先进的造口产品时面临经济障碍。袋子和配件的经常性费用进一步加重了患者的负担，降低了采用率。医疗保健系统的报销政策因地区而异，进一步影响了负担能力。这些挑战阻碍了造口护理设备的广泛普及，尤其是在服务不足的市场。

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动态

  • 影响因素
    • 驱动程式
      • 发炎性肠道疾病率上升
      • 已开发市场优惠的报销政策
    • 限制
      • 高成本和有限的报销政策
      • 严格的监管要求
    • 机会
      • 拓展新兴市场
    • 影响分析

第五章：战略洞察与产业展望

  • 市场领导者和先驱者
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的成熟领导者
    • 拥有成熟产品的市场领导者
  • CXO 观点
  • 最新进展与突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 管道分析
  • 供应链分析
  • 专利分析
  • SWOT 分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态
  • 关键意见领袖

第 6 章：依产品类型

  • 造口袋
  • 一体式系统
  • 两件式系统
  • 配件
  • 造口粉
  • 黏合剂和密封剂
  • 造口糊剂
  • 其他的

第 7 章：按应用

  • 结肠造口术
  • 迴肠造口术
  • 尿路造口术
  • 其他的

第 8 章：按最终用户

  • 医院
  • 门诊手术中心 (ASC)
  • 家庭护理设置

第九章：按地区

  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 拉丁美洲
    • 墨西哥
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 10 章：竞争格局

  • 竞争格局
  • 市场定位/份额分析
  • 併购分析

第 11 章：公司简介

  • Coloplast A/S
    • 公司概况
    • 产品组合
      • 产品描述
      • 产品关键绩效指标 (KPI)
      • 历史和预测产品销售量
      • 产品销售量
    • 财务概览
      • 公司收入
      • 地区收入份额
      • 收入预测
    • 主要进展
      • 合併与收购
      • 关键产品开发活动
      • 监管部门批准等
    • SWOT 分析
  • Hollister Incorporated
  • ConvaTec Group PLC
  • B. Braun Melsungen AG
  • 3M Company
  • Welland Medical Limited
  • Salts Healthcare Ltd
  • Torbot Group Inc
  • Byram Healthcare
  • Sarasota Medical Products
  • Similar data will be provided for each market player.
  • 马伦製造与开发公司
    • 管道产品描述
    • 产品关键绩效指标 (KPI)
    • 主要活动
    • 市场进入时间表
    • 产品渗透率
    • 销售估计和预测
  • Cymed 造口公司
  • Schena 造口技术有限公司
  • 阿尔卡雷有限公司
  • 将为每个市场参与者提供类似的资料。

第 12 章：附录

简介目录
Product Code: MD9290

The global ostomy care devices market reached US$ 3.54 billion in 2024 and is expected to reach US$ 7.51 billion by 2033, growing at a CAGR of 7.8% during the forecast period 2025-2033.

Ostomy care devices are medical products used to assist individuals with ostomy surgery, such as colostomy, ileostomy, or urostomy, managing waste and ensuring patient comfort. Advancements in technology, odor control, leak prevention, and skin-friendly materials enhance patient quality of life. The ostomy care devices market encompasses the production, distribution, and sale of products designed to support individuals who have undergone an ostomy procedure.

An ostomy involves surgically diverting part of the digestive or urinary system to an external opening on the body, known as a stoma. This procedure is commonly performed for patients dealing with conditions such as colorectal cancer, inflammatory bowel diseases (like Crohn's disease and ulcerative colitis), bladder cancer, and certain congenital disorders.

Market Dynamics: Drivers & Restraints

Rising Prevalence of Inflammatory Bowel Diseases

The global ostomy care devices market is booming due to the rise in inflammatory bowel diseases (IBD), such as Crohn's and ulcerative colitis. These chronic conditions often require surgical interventions, leading to increased demand for ostomy care products. The growing incidence of IBD, particularly in developed countries, is attributed to changing dietary habits, stress, and genetic predispositions.

For instance, A 2024 study estimated that 2.39 Billion Americans have IBD, including 1.25 million with ulcerative colitis and 1.01 million with Crohn's disease. The highest rates of IBD are in North America, with 721 cases per 100,000 person-years in the US. The prevalence of ulcerative colitis is higher than Crohn's disease, but Crohn's disease is more prevalent among children under 10 years.

The increasing prevalence of IBD, affecting 2.39 million Americans, drives demand for ostomy care devices, particularly in North America, where the region has the highest rates, resulting in significant market growth for advanced ostomy products and accessories.

High Cost and Limited Reimbursement Policies

The demand for ostomy care devices is increasing, but high product costs and inadequate reimbursement policies hinder market growth. Patients, particularly in low- and middle-income countries, face financial barriers to access advanced ostomy products. Recurring costs of pouches and accessories further burden patients, reducing adoption rates. Healthcare systems' reimbursement policies vary across regions, further affecting affordability. These challenges hinder widespread accessibility of ostomy care devices, especially in underserved markets.

Segment Analysis

The global ostomy care devices market is segmented based on product type, application, end user and region.

Product Type:

Ostomy bags segment is expected to dominate the ostomy care devices with the highest market share

Ostomy bags are medical devices used to collect waste from the abdomen after a surgical procedure, particularly for individuals with gastrointestinal disorders like IBD or colorectal cancer. They come in one-piece and two-piece systems, with modern designs enhancing comfort and hygienic waste management, improving patient quality of life.

The ostomy bags segment is the top choice in the global ostomy care devices market due to their crucial role in waste management for individuals undergoing ostomy procedures. Unlike other accessories, ostomy bags are a primary necessity for patients, making them the most in-demand product category. They come in one-piece and two-piece systems, with one-piece systems being preferred for simplicity and ease of use, while two-piece systems offer flexibility and longer wear time.

Geographical Analysis

North America is expected to hold a significant position in the ostomy care devices market share

North America holds a substantial position in the ostomy care devices market and is expected to hold most of the market due to significant product launches, rising prevalence of IBD, colorectal cancer, and other gastrointestinal disorders. The region's healthcare infrastructure, key players, continuous product innovations, and favourable reimbursement policies drive market growth. The aging population fuels demand for high-quality ostomy bags and accessories.

For instance, in April 2024, Convatec launched Esteem Body with Leak Defense in the US, addressing the growing use of soft convexity ostomy barriers due to global obesity, which has nearly tripled since 1975. This trend has led to changes in abdominal topography and challenges in ostomy care management.

Hence, Convatec's launch of Esteem Body with Leak Defense in April 2024 enhances the ostomy care market by addressing the rising demand for soft convexity ostomy barriers, driven by increasing obesity rates. This innovation improves patient comfort and leak prevention, fostering market growth through higher adoption and advanced ostomy care solutions.

Competitive Landscape

The major global players in the ostomy care devices market include Coloplast A/S, Hollister Incorporated, ConvaTec Group PLC, B. Braun Melsungen AG, 3M Company, Welland Medical Limited, Salts Healthcare Ltd, Torbot Group Inc., Byram Healthcare and Sarasota Medical Products among others.

Key Developments

  • In July 2024, Revel, a leading ostomy care brand, introduced its first product, It's in the Bag, a deodorizing lubricant developed using LiquiGlide, an MIT-engineered technology. This product offers durable, self-lubricating, slippery surfaces and sets category-leading laboratory testing benchmarks, aiming to improve quality-of-life for ostomates.
  • In May 2024, Coloplast received reimbursement approval for the world's first digital leakage notification system, Heylo, and expanded its SenSura Mio ostomy range with two new products. The company's 2025 strategy, Strive25, aims to raise the standard of care for users and bring new products to market at a higher pace. Heylo detects potential leakages under the ostomy baseplate, notifying users at an early stage to prevent leakage progression.

Why Purchase the Report?

  • Technological Innovations: Reviews ongoing product launches and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

The global ostomy care devices market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Application
  • 3.3. Snippet by End User
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Rising Prevalence of Inflammatory Bowel Diseases
      • 4.1.1.2. Favorable Reimbursement Policies in Developed Markets
    • 4.1.2. Restraints
      • 4.1.2.1. High Cost and Limited Reimbursement Policies
      • 4.1.2.2. Stringent Regulatory Requirements
    • 4.1.3. Opportunity
      • 4.1.3.1. Expansion into Emerging Markets
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with the largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Pipeline Analysis
  • 5.8. Supply Chain Analysis
  • 5.9. Patent Analysis
  • 5.10. SWOT Analysis
  • 5.11. Unmet Needs and Gaps
  • 5.12. Recommended Strategies for Market Entry and Expansion
  • 5.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.14. Pricing Analysis and Price Dynamics
  • 5.15. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Ostomy Bags*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. One-piece Systems
  • 6.4. Two-piece Systems
  • 6.5. Accessories
  • 6.6. Stoma Powder
  • 6.7. Adhesives and Sealants
  • 6.8. Stoma Paste
  • 6.9. Others

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Colostomy*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Ileostomy
  • 7.4. Urostomy
  • 7.5. Others

8. By End User

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 8.1.2. Market Attractiveness Index, By End User
  • 8.2. Hospitals*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Ambulatory Surgical Centers (ASCs)
  • 8.4. Home Care Settings

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Spain
      • 9.3.6.5. Italy
      • 9.3.6.6. Rest of Europe
  • 9.4. Latin America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Mexico
      • 9.4.6.2. Brazil
      • 9.4.6.3. Argentina
      • 9.4.6.4. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. South Korea
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

Key Market Players

  • 11.1. Coloplast A/S*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio
      • 11.1.2.1. Product Description
      • 11.1.2.2. Product Key Performance Indicators (KPIs)
      • 11.1.2.3. Historic and Forecasted Product Sales
      • 11.1.2.4. Product Sales Volume
    • 11.1.3. Financial Overview
      • 11.1.3.1. Company Revenue's
      • 11.1.3.2. Geographical Revenue Shares
      • 11.1.3.3. Revenue Forecasts
    • 11.1.4. Key Developments
      • 11.1.4.1. Mergers & Acquisitions
      • 11.1.4.2. Key Product Development Activities
      • 11.1.4.3. Regulatory Approvals etc.
    • 11.1.5. SWOT Analysis
  • 11.2. Hollister Incorporated
  • 11.3. ConvaTec Group PLC
  • 11.4. B. Braun Melsungen AG
  • 11.5. 3M Company
  • 11.6. Welland Medical Limited
  • 11.7. Salts Healthcare Ltd
  • 11.8. Torbot Group Inc
  • 11.9. Byram Healthcare
  • 11.10. Sarasota Medical Products
  • Similar data will be provided for each market player.

Emerging Market Players

  • 11.11. Marlen Manufacturing & Development Co*
    • 11.11.1. Pipeline Products Description
    • 11.11.2. Product Key Performance Indicators (KPIs)
    • 11.11.3. Key Activities
    • 11.11.4. Market Entry Timelines
    • 11.11.5. Product Penetration Rate
    • 11.11.6. Sales Estimation and Projections
  • 11.12. Cymed Ostomy Co.
  • 11.13. Schena Ostomy Technologies, Inc.
  • 11.14. Alcare Co., Ltd.
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1 About Us and Services
  • 12.2 Contact Us